influenza
virus
influenza
virus
compris
three
type
b
c
virus
plu
subtyp
strain
within
type
envelop
virus
contain
singlestrand
rna
diamet
niu
belong
famili
orthomyxovirida
influenza
virus
diagnost
specimen
lose
infect
within
sever
day
room
temperatur
maintain
infect
one
week
influenza
infecti
diseas
consist
associ
signific
increas
nation
mortal
epidem
infect
influenza
virus
may
asymptonlat
per
cent
infect
individu
caus
symptom
rang
common
cold
fatal
pneumonia
sever
ill
partli
depend
level
preexist
antibodi
infect
strain
age
individu
presenc
chronic
underli
diseas
infect
confer
longterm
strainspecif
immun
frequent
chang
surfac
antigen
influenza
virus
result
lifelong
suscept
addit
infect
minor
chang
hemagglutinin
h
neuraminidas
n
antigen
influenza
b
may
associ
epidem
major
chang
h
n
antigen
influenza
lead
worldwid
pandem
current
influenza
virus
import
influenza
virus
clinic
epidemiolog
standpoint
infect
person
age
group
associ
excess
mortal
seven
nine
period
epidem
activ
unit
state
sinc
eiuerg
influenza
viru
caus
ill
primarili
among
children
adolesc
young
adult
follow
reemerg
associ
excess
influenza
b
virus
tend
caus
epidem
interv
primarili
affect
young
person
although
elderli
may
also
experi
ill
excess
mortal
observ
influenza
season
influenza
c
virus
associ
mild
sporad
occur
ill
smallparticl
aerosol
believ
common
iuod
transmiss
influenza
virus
incub
period
vari
hour
diagnosi
influenza
often
base
sole
consist
clinic
pictur
presenc
influenza
epidem
commun
infect
reliabl
confirm
viral
isol
primari
monkey
kidney
cell
embryon
hen
egg
although
fa
stain
respiratoryspec
imen
detect
per
cent
infect
confirm
isol
influenza
infect
also
detect
instanc
rise
typeor
subtypespecif
antibodi
four
serotyp
two
subtyp
parainfluenza
type
identifi
envelop
virus
diamet
nm
contain
singl
strand
rna
belong
famili
paramyxovirida
parainfluenza
virus
lose
infect
room
temperatur
within
sever
day
maintain
infect
long
one
week
parainfluenza
virus
probabl
second
rhi
influenza
virus
compris
three
type
b
c
virus
plu
subtyp
strain
within
type
envelop
virus
contain
singlestrand
rna
diamet
nm
belong
famili
orthomyxovirida
influenza
virus
diagnost
specimen
lose
infect
within
sever
day
room
temperatur
maintain
infect
c
one
week
influenza
infecti
diseas
consist
associ
signific
increas
nation
mortal
epidem
infect
influenza
virus
may
asymptomat
per
cent
infect
individu
caus
symptom
rang
common
cold
fatal
pneumonia
sever
ill
partli
depend
level
preexist
antibodi
infect
strain
age
individu
presenc
chronic
underli
diseas
infect
confer
longterm
strainspecif
immun
frequent
chang
surfac
antigen
influenza
virus
result
lifelong
suscept
addit
infect
minor
chang
hemagglutinin
h
neuraminidas
n
antigen
influenza
b
may
associ
epidem
major
chang
horn
antigen
influenza
lead
worldwid
pandem
current
influenza
virus
import
influenza
virus
clinic
epidemiolog
standpoint
infect
person
age
group
associ
excess
mortal
seven
nine
period
epidem
activ
unit
state
sinc
emerg
influenza
hinl
viru
caus
ill
primarili
among
children
adolesc
young
adult
follow
reemerg
associ
excess
mortal
influenza
b
virus
tend
caus
epidem
interv
primarili
affect
young
person
although
elderli
may
also
experi
ill
excess
mortal
observ
influenza
season
influenza
c
virus
associ
mild
sporad
occur
ill
smallparticl
aerosol
believ
common
mode
transmiss
influenza
incub
period
vari
hour
diagnosi
influenza
often
base
sole
consist
clinic
pictur
presenc
influenza
epidem
commun
infect
reliabl
confirm
viral
isol
primari
monkey
kidney
cell
embryon
hen
egg
although
fa
stain
respiratori
specimen
detect
per
cent
infect
confirm
isul
influenza
infect
also
detect
instanc
rise
typeor
subtypespecif
antibodi
four
serotyp
two
subtyp
parainfluenza
type
identifi
envelop
virus
diamet
nm
contain
singl
strand
rna
belong
famili
paramyxovirida
parainfluenza
virus
lose
infect
room
temperatur
within
sever
day
maintain
infect
long
one
week
parainfluenza
virus
probabl
second
rhinovirus
caus
respiratori
ill
human
spectrum
epidelniolog
diseas
vari
age
popul
serotyp
respiratori
syncyti
viru
common
parainfluenza
caps
pneumonia
bronchiol
children
year
age
parainfluenza
viru
may
isol
throughout
year
peak
ill
often
occur
fall
spring
parainfluenza
viru
type
lead
caus
croup
children
signific
caus
childhood
pneumonia
produc
peak
incid
infect
year
age
occur
primarili
epidem
parainfluenza
less
frequent
isol
serolog
studi
suggest
common
infect
appar
caus
mild
asymptomat
infect
person
infect
parainfluenza
virus
age
recurr
infect
throughout
life
reinfect
adult
usual
caus
mild
upper
respiratori
tract
infect
also
caus
sever
ill
includ
pneumonia
rate
reinfect
decreas
titer
serum
neutral
antibodi
increas
protect
reinfect
appear
better
correl
antibodi
nasal
secret
antibodi
serum
mode
transmiss
parainfluenza
viru
well
studi
although
transmiss
appear
direct
persontoperson
andor
droplet
aerosol
spread
incub
period
rang
day
viru
isol
day
longer
onset
ill
fa
ria
elisa
test
capabl
detect
viral
antigen
per
cent
respiratori
secret
yield
viru
isol
falseposit
result
iso
isol
clinic
set
complic
fact
sensit
cell
line
primari
rhesu
monkey
kidney
gener
avail
serolog
diagnosi
parainfluenza
viral
infect
hamper
heterolog
antibodi
respons
among
four
type
mump
viru
inconsist
homolog
antibodi
respons
differ
serotyp
rhinoviru
identifi
far
rhinovirus
small
nm
diamet
contain
singlestrand
rna
nonenvelop
belong
famili
picornavirida
rel
stabl
virus
surviv
long
three
day
dri
environment
surfac
rhinovirus
believ
common
respiratori
pathogen
man
caus
primarili
mild
upper
respiratori
symptom
common
cold
also
caus
lower
respiratori
tract
ill
includ
pneumonia
adult
children
approxim
per
cent
infect
symptomat
temper
climat
rhinoviru
infect
occur
throughout
year
peak
fall
spring
peak
season
multipl
type
rhinovirus
may
simultan
present
commun
higher
number
type
untyp
rhinovirus
appear
becom
common
lower
number
type
suggest
antigen
drift
among
rhinovirus
reinfect
demonstr
infect
presenc
typespecif
serum
neutral
antibodi
also
occur
rate
reinfect
howev
decreas
increas
novirus
caus
respiratori
ill
human
spectrum
epidemiolog
diseas
vari
age
popul
serotyp
respiratori
syncyti
viru
common
parainfluenza
ca
use
pneumonia
bronchiol
children
year
age
parainfluenza
viru
may
isol
throughout
year
peak
ill
often
occur
fall
spring
parainfluenza
viru
type
lead
caus
croup
children
signific
caus
childhood
pneumonia
produc
peak
incid
infect
year
age
occur
primarili
epidem
parainfluenza
less
frequent
isol
serolog
studi
suggest
common
infect
appar
caus
mild
asymptomat
infect
person
infect
parainfluenza
virus
age
recurr
infect
throughout
life
reinfect
adult
usual
caus
mild
upper
respiratori
tract
infect
also
caus
sever
ill
includ
pneumonia
rate
reinfect
decreas
titer
serum
neutral
antibodi
increas
protect
reinfect
appear
better
correl
antibodi
nasal
secret
antibodi
serum
mode
transmiss
parainfluenza
viru
well
studi
although
transmiss
appear
direct
persontoperson
andor
droplet
aerosol
spread
incub
period
rang
day
viru
isol
day
longer
onset
ill
fa
ria
elisa
test
capabl
detect
viral
antigen
per
cent
respiratori
secret
yield
viru
isol
falseposit
result
isol
clinic
set
complic
fact
sensit
cell
line
primari
rhesu
monkey
kidney
gener
avail
serolog
diagnosi
parainfluenza
viral
infect
hamper
heterolog
antibodi
respons
among
four
type
mump
viru
inconsist
homolog
antibodi
respons
differ
serotyp
rhinoviru
identifi
far
rhinovirus
small
nm
diamet
contain
singlestrand
rna
nonenvelop
belong
famili
picornavirida
rel
stabl
virus
surviv
long
three
day
dri
environment
surfac
rhinovirus
believ
common
respiratori
pathogen
man
caus
primarili
mild
upper
respiratori
symptom
common
cold
also
caus
lower
respiratori
tract
ill
includ
pneumonia
adult
children
approxim
per
cent
infect
symptomat
temper
climat
rhinoviru
infect
occur
throughout
year
peak
fall
spring
peak
season
multipl
type
rhinovirus
may
simultan
present
commun
higher
number
type
untyp
rhinovirus
appear
becom
common
lower
number
type
suggest
antigen
drift
among
rhinovirus
reinfect
demonstr
infect
presenc
typespecif
serum
neutral
antibodi
also
occur
rate
reinfect
howev
decreas
increas
titer
neutral
antibodi
antigen
drift
reinfect
numer
serotyp
may
contribut
frequenc
rhinoviru
infect
rhinovirus
readili
transmit
autoinocul
hand
contamin
direct
persontoperson
contact
fomit
effici
site
inocul
nasal
mucosa
conjunctiva
incub
period
one
three
day
viru
readili
isol
four
six
day
sometim
four
week
onset
identifi
rhinoviru
infect
difficult
numer
serolog
type
neither
test
antibodi
rise
serum
presenc
antigen
respiratori
secret
present
practic
isol
rhinovirus
also
difficult
sinc
may
grow
poorli
even
normal
sensit
cell
line
respiratori
syncyti
viru
although
sever
strain
respiratori
syncyti
viru
rsv
known
strain
differ
yet
shown
epidemiolog
clinic
signific
rsv
envelop
viru
diamet
nm
contain
singlestrand
rna
belong
famili
paramyxovirida
labil
viru
titer
rsv
drop
within
day
room
temperatur
loofold
within
day
rsv
import
caus
lower
respiratori
tract
diseasepneumonia
bronchiolitisin
children
year
age
worldwid
respiratori
viru
influenza
caus
epidem
year
epidem
occur
late
fall
spring
last
month
role
host
immun
respons
play
pathogenesi
rsv
diseas
unclear
rsv
uniqu
among
viral
diseas
abil
caus
seriou
ill
among
infant
despit
presenc
matern
neutral
reinfect
rsv
occur
throughout
life
older
children
adult
serum
neutral
antibodi
prevent
may
amelior
ill
antibodi
respiratori
secret
may
play
larger
role
prevent
infect
adult
rsv
usual
caus
mild
upper
respiratori
tract
infect
although
also
produc
sever
ill
includ
pneumonia
especi
elderli
rsv
transmit
direct
persontoperson
spread
andor
bydroplet
aerosol
spread
fomit
symptom
occur
four
five
day
initi
infect
viru
usual
isol
respiratori
tract
three
five
day
longer
isol
rsv
accomplish
virolog
laboratori
elisa
fa
test
rsv
antigen
respiratori
specimen
shown
sensit
per
cent
compar
isol
specif
practic
infect
also
demonstr
rise
serum
antibodi
titer
sever
differ
test
virus
caus
respiratori
ill
mani
virus
caus
respiratori
ill
alon
part
syndrom
herp
simplex
especi
type
epsteinbarr
viru
ebv
signific
caus
pharyng
rubella
rubeola
varicella
caus
symptom
upper
respiratori
tract
infect
onset
typic
rash
mump
caus
upper
respiratori
tract
l
j
anderson
p
patriarca
j
c
hierjiolz
c
r
nobl
titer
neutral
antigen
drift
reinfect
numer
serotyp
may
contribut
frequenc
rhinoviru
infect
rhinovirus
readili
transmit
auto
inocul
hand
contamin
direct
persontaperson
contact
fomit
effici
site
inocul
nasal
mucosa
conjunctiva
incub
period
one
three
day
viru
readili
isol
four
six
day
sometim
four
week
onset
identifi
rhinoviru
infect
difficult
numer
serolog
type
neither
test
antibodi
rise
serum
presenc
antigen
respiratori
secret
present
practic
isol
rhinovirus
also
difficult
sinc
may
grow
poorli
even
normal
sensit
celllin
although
sever
strain
respiratori
syncyti
viru
rsv
known
strain
differ
yet
shown
epidemiolog
clinic
signific
rsv
envelop
viru
diamet
nm
contain
singlestrand
rna
belong
famili
paramyxoviridael
labil
viru
titer
rsv
drop
within
day
room
temperatur
wofold
within
day
c
rsv
import
caus
lower
respiratori
tract
diseasepneumonia
bronchiolitisin
children
year
age
worldwid
respiratori
viru
influenza
caus
epidem
year
epidem
occur
late
fall
spring
last
month
role
host
immun
respons
play
pathogenesi
rsv
diseas
unclear
rsv
uniqu
among
viral
diseas
abil
caus
seriou
ill
among
infant
despit
presenc
matern
neutral
antibodi
reinfect
rsv
occur
throughout
life
older
children
adult
serum
neutral
antibodi
prevent
may
amelior
ill
antibodi
respiratori
secret
may
play
larger
role
prevent
infectionl
adult
rsv
usual
caus
mild
upper
respiratori
tract
infect
although
also
produc
sever
ill
includ
pneumonia
especi
elderli
rsv
transmit
direct
persontoperson
spread
andor
droplet
aerosol
spread
fomit
symptom
occur
four
five
day
initi
infect
viru
usual
isol
respiratori
tract
three
five
day
longer
isol
rsv
accomplish
virolog
laboratori
elisa
fa
test
rsv
antigen
respiratori
specimen
shown
sensit
per
cent
compar
isol
specif
practic
infect
also
demonstr
rise
serum
antibodi
titer
sever
differ
test
virus
caus
respiratori
ill
mani
virus
caus
respiratori
ill
alon
part
syndrom
herp
simplex
especi
type
epsteinbarr
viru
ebv
signific
caus
pharyng
rubella
rubeola
varicella
caus
symptom
upper
respiratori
tract
infect
onset
typic
rash
mump
caus
upper
respiratori
tract
infect
without
typic
parot
bk
viru
nonenvelop
doublestrand
dna
viru
famili
papovavirida
recent
associ
respiratori
ill
infect
respiratori
tract
bk
viru
common
bk
viru
may
caus
per
cent
acut
respiratori
diseas
virtual
enteroviru
type
includ
poliovirus
coxsacki
b
virus
echovirus
enteroviru
caus
respiratori
tract
ill
e
upper
respiratori
tract
infect
pharyng
pneumonia
acut
respiratori
diseas
militari
recruit
enteroviru
infect
occur
commonli
children
summer
fall
month
per
cent
infect
symptomat
viral
respiratori
syndrom
artifici
categori
taken
continuum
ill
rang
asymptomat
infect
lifethreaten
pneumonia
although
artifici
categori
provid
conveni
way
discuss
caus
agent
gener
epidemiolog
featur
viral
respiratori
diseas
clinic
perspect
viral
upper
respiratori
tract
ill
uri
common
cold
probabl
common
human
infect
major
caus
morbid
visit
physician
time
lost
work
unit
state
uri
character
nasal
discharg
nasal
obstruct
sneez
sore
throat
cough
without
fever
ill
usual
last
day
persist
sever
week
longer
common
complic
viral
uri
sinus
otiti
media
estim
occur
per
cent
respect
famili
member
one
studi
temper
climat
prime
season
uri
begin
late
summer
earli
fall
continu
late
spring
season
consist
sequenti
outbreak
infect
caus
differ
virus
respiratori
syncyti
viru
influenza
virus
coronavirus
rhinovirus
endem
infect
virus
adenovirus
parainfluenza
viru
thu
given
time
viru
like
respons
syndrom
vari
greatli
commonli
identifi
agent
uri
among
adult
rhinovirus
follow
coronavirus
tabl
virus
may
also
caus
signific
portion
uri
unknown
etiolog
sinc
difficult
identifi
virus
infect
rhinovirus
coronavirus
rel
less
common
children
infect
respiratori
syncyti
viru
parainfluenza
virus
adenovirus
common
although
pharyng
often
part
symptom
complex
common
cold
influenza
syndrom
caus
differ
viral
respihatori
ill
tion
without
typic
parot
bk
viru
non
envelop
doublestrand
dna
viru
famili
papovavirida
recent
associ
respiratori
ill
infect
respiratori
tract
bk
viru
common
bk
viru
may
caus
per
cent
acut
respiratori
diseas
virtual
enteroviru
type
includ
poliovirus
coxsacki
b
virus
echovirus
enteroviru
caus
respiratori
tract
ill
e
upper
respiratori
tract
infect
pharyng
pneumonia
acut
respiratori
diseas
militari
recruit
enteroviru
infect
occur
commonli
children
summer
fall
month
per
cent
infect
symptomat
viral
respiratori
syndrom
artifici
categori
taken
continuum
ill
rang
asymptomat
infect
lifethreaten
pneumonia
although
artifici
categori
provid
conveni
way
discuss
caus
agent
gener
epidemiolog
featur
viral
respiratori
diseas
clinic
perspect
viral
upper
respiratori
tract
ill
uri
common
cold
probabl
common
human
infect
major
caus
morbid
visit
physician
time
lost
work
unit
state
uri
character
nasal
discharg
nasal
obstruct
sneez
sore
throat
cough
without
fever
ill
usual
last
day
persist
sever
week
longer
common
complic
viral
uri
sinus
otiti
media
estim
occur
per
cent
respect
famili
member
one
studv
temper
cliat
prime
season
uri
begin
late
summer
earli
fall
continu
late
spring
season
consist
sequenti
outbreak
infect
caus
differ
virus
respiratori
syncyti
viru
influenza
virus
coronavirus
rhinovirus
endem
infect
virus
adenovirus
parainfluenza
viru
thu
given
time
viru
like
respons
syndrom
vari
greatli
commonli
identifi
agent
uri
among
adult
rhinovirus
follow
coronavirus
tabl
virus
may
also
caus
signific
portion
uri
unknown
etiolog
sinc
difficult
identifi
virus
infect
rhinovirus
coronavirus
rel
less
common
children
infect
respiratori
syncyti
viru
parainfluenza
virus
adenovirus
common
pharyng
although
pharyng
often
part
symptom
complex
common
cold
influenza
syndrom
caus
differ
group
etiolog
agent
see
tabl
although
usual
clinic
featur
pharyng
accompani
symptom
differ
among
agent
overlap
clinic
pictur
make
imposs
determin
caus
agent
clinic
ground
alon
howev
certain
symptom
complex
like
viral
pharyng
vesicl
pharyng
rhinorrhea
nasal
obstruct
pharyng
conjunct
temper
climat
peak
season
pharyng
coincid
uri
influenza
syndrom
character
abrupt
onset
fever
headach
sever
myalgia
malais
prostrat
lnanifest
typic
resolv
within
one
five
day
although
cough
nasal
congest
sore
throat
may
becom
promin
cough
lassitud
persist
two
week
even
uncompl
case
affect
individu
recov
spontan
symptomat
therapi
lower
respiratori
tract
complic
may
occur
per
cent
particularli
elderli
certain
chronic
disord
complic
includ
myositi
myocard
rey
rare
occur
influenza
viral
infect
influenza
virus
common
caus
influenza
syndrom
civilian
popul
although
adenovirus
major
caus
militari
train
camp
respiratori
virus
includ
also
implic
influenza
syndrom
see
tabl
symptom
tracheobronch
cough
expector
without
pneumonia
commonli
associ
viral
respiratori
infect
especi
influenza
parainfluenza
virus
respiratori
syncyti
vi
group
etiolog
agent
see
tabl
although
usual
clinic
featur
pharyng
accompani
symptom
differ
among
agent
overlap
clinic
pictur
make
imposs
determin
caus
agent
clinic
ground
alon
howev
certain
symptom
complex
like
viral
pharyng
vesicl
pharyng
rhinorrhea
nasal
obstruct
pharyng
conjunct
temper
climat
peak
season
pharyng
coincid
uri
influenza
syndrom
character
abrupt
onset
fever
headach
sever
myalgia
malais
prostrat
manifest
typic
resolv
within
one
five
day
although
cough
nasal
congest
sore
throat
may
becom
promin
cough
lassitud
persist
two
week
even
uncompl
case
affect
individu
recov
spontan
symptomat
therapi
lower
respiratori
tract
complic
may
occur
per
cent
particularli
elderli
certain
chronic
disord
complic
includ
myositi
myocard
enceph
rey
syndrom
rare
occur
influenza
viral
infect
influenza
virus
common
caus
influenza
syndrom
civilian
popul
although
adenovirus
major
caus
militari
train
camp
respiratori
virus
includ
also
implic
influenza
syndrom
see
tabl
symptom
tracheobronch
cough
expector
without
pneumonia
commonli
associ
viral
respiratori
infect
especi
influenza
parainfluenza
virus
respiratori
syncyti
viru
adenoviru
person
viral
respiratori
infect
appear
increas
risk
bronchiti
smoker
exalnpl
may
increas
frequenc
durat
cough
rhinoviru
influenza
infect
patient
asthma
chronic
bronchiti
may
experi
exacerb
ill
viral
respiratori
infect
associ
sign
symptom
fever
rhinorrhea
myalgia
pharyng
usual
present
first
three
six
day
ill
cough
expector
may
last
sever
addit
week
acut
bronchiti
commonli
occur
viral
respiratori
season
fall
winter
spring
usual
caus
respiratori
virus
mycoplasma
pneumonia
largescal
investig
past
two
decad
suggest
virus
rel
uncommon
caus
pneumonia
adult
account
per
cent
nonbacteri
pneumonia
per
cent
radiolog
proven
pneumonia
respiratori
virus
except
coronavirus
implic
communityacquir
viral
pneumonia
influenza
viru
establish
common
caus
primari
influenza
pneumonia
observ
b
viru
type
sever
rel
mild
ill
sever
primari
influenza
pneumonia
report
commonli
elderli
patient
individu
chronic
lung
heart
diseas
epidem
women
late
stage
type
pneumonia
also
detect
patient
underli
predisposit
character
rapid
relentless
progress
respiratori
distress
diffus
alveolar
interstiti
infiltr
patient
die
despit
intens
support
care
mild
influenza
pneumonia
commonli
occur
younger
patient
character
persist
cough
respiratori
distress
spars
segment
infiltr
patient
usual
recov
complet
secondari
bacteri
pneumonia
mix
viral
bacteri
pneumonia
accompani
influenza
infect
frequent
primari
influenza
pneumonia
elderli
patient
certain
chronic
underli
disord
highest
risk
secondari
bacteri
pneumonia
usual
present
recrudesc
fever
product
cough
day
onset
influenza
syndrom
chest
roentgenogram
show
area
consolid
streptococcu
pneumonia
staphylococcu
aureu
hemophilu
injluenza
colnmon
pathogen
advent
specif
antivir
chemotherapi
increas
awar
nosocomi
viral
infect
diagnosi
viral
infect
becom
increasingli
import
diagnost
test
avail
clinician
includ
serolog
antigen
detect
test
viral
isol
serolog
test
advantag
serum
specimen
gener
easier
ru
adenoviru
person
viral
respiratori
infect
appear
increas
risk
bronchiti
smoker
exampl
may
increas
frequenc
durat
cough
rhinoviru
influenza
patient
asthma
chronic
bronchiti
may
experi
exacerb
ill
viral
respiratori
infect
associ
sign
symptom
fever
rhinorrhea
myalgia
pharyng
usual
present
first
three
six
day
ill
cough
expector
may
last
sever
addit
week
acut
bronchiti
commonli
occur
viral
respiratori
season
fall
winter
spring
usual
caus
respiratori
virus
mycoplasma
pneumonia
primari
influenza
pneumonia
observ
b
viru
type
sever
rel
mild
ill
sever
primari
influenza
pneumonia
report
commonli
elderli
patient
individu
chronic
lung
heart
diseas
epidem
women
late
stage
type
pneumonia
also
detect
patient
underli
predisposit
character
rapid
relentless
progress
respiratori
distress
diffus
alveolar
interstiti
infiltr
patient
die
despit
intens
support
care
mild
influenza
pneumonia
commonli
occur
younger
patient
character
persist
cough
respiratori
distress
spars
segment
infiltr
patient
usual
recov
complet
secondari
bacteri
pneumonia
mix
viral
bacteri
pneumonia
accompani
influenza
infect
frequent
primari
influenza
pneumonia
elderli
patient
certain
chronic
underli
disord
highest
risk
secondari
bacteri
pneumonia
usual
present
recrudesc
fever
product
cough
day
onset
influenza
syndrom
chest
roentgenogram
show
area
consolid
streptococcu
pneumonia
staphylococcu
aureu
hemophilu
injluenza
common
pathogen
advent
specif
antivir
chemotherapi
increas
awar
nosocomi
viral
infect
diagnosi
viral
infect
becom
increasingli
import
diagnost
test
avail
clinician
includ
serolog
antigen
detect
test
viral
isol
serolog
test
advantag
serum
specimen
gener
easier
handl
transport
test
requir
acut
convalesc
sera
comparison
antibodi
titer
consequ
result
usual
avail
clinic
use
igm
test
rapid
diagnosi
respiratori
virus
yet
develop
gener
use
serolog
test
also
hamper
inconsist
antibodi
respons
reinfect
unavail
screen
test
rhinovirus
coronavirus
major
advantag
rapid
antigen
detect
test
clinic
specimen
complet
one
two
day
result
still
clinic
use
serolog
test
howev
screen
test
avail
rhinovirus
coronavirus
viral
isol
hand
requir
specif
test
particular
viru
though
may
detect
appropri
cell
cultur
use
coronaviru
almost
never
isol
gener
viral
isol
sensit
antigen
detect
take
longer
expens
use
test
effect
requir
specimen
collect
appropri
time
handl
correctli
result
interpret
light
sensit
specif
particular
test
detect
chang
antibodi
titer
acutephas
serum
drawn
soon
possibl
onset
ill
prefer
within
three
four
day
convalescentserum
two
four
week
later
antigen
detect
test
viral
isol
specimen
collect
soon
possibl
onset
ill
prefer
within
three
four
day
viral
isol
antigen
detect
nasopharyng
aspir
wash
prefer
nasopharyng
throat
swab
identifi
rsv
one
studi
show
nearli
increas
isol
rate
nasopharyng
wash
colnpar
nasopharyng
swab
isol
respiratori
virus
respiratori
secret
gener
provid
etiolog
diagnosi
although
care
need
interpret
signific
adenoviru
herpesviru
isol
sinc
shed
may
prolong
test
sensit
specif
depend
skill
person
perform
test
especi
fa
qualiti
reagent
thu
result
one
laboratori
may
quit
differ
froln
anoth
clinician
awar
sensit
specif
test
perform
laboratori
use
diagnosi
viral
respiratori
infect
like
increasingli
reli
rapid
detect
test
clinic
specimen
antigen
detect
monoclon
antibodi
like
commonli
use
reagent
sinc
provid
sensit
specif
compar
anim
antiserum
without
variabl
qualiti
test
detect
viral
dna
virusspecif
compon
clinic
specimen
also
develop
may
improv
abil
detect
viral
respiratori
infect
nosocomi
viral
infect
increasingli
recogn
import
problem
studi
shown
caus
signific
morbid
prolong
hospit
death
especi
among
infant
handl
transport
test
requir
acut
convalesc
sera
comparison
antibodi
titer
consequ
result
usual
avail
clinic
use
igm
test
rapid
diagnosi
respiratori
virus
yet
develop
gener
use
serolog
test
also
hamper
inconsist
antibodi
respons
reinfect
unavail
screen
test
rhinovirus
coronavirus
major
advantag
rapid
antigen
detect
test
clinic
specimen
complet
one
two
day
result
still
clinic
use
serolog
test
howev
screen
test
avail
rhinovirus
coronavirus
viral
isol
hand
requir
specif
test
particular
viru
though
may
detect
appropri
cell
cultur
use
coronaviru
almost
never
isol
gener
viral
isol
sensit
antigen
detect
take
longer
expens
u
sing
test
effect
requir
specimen
collect
appropri
time
handl
correctli
result
interpret
light
sensit
specif
particular
test
detect
chang
antibodi
titer
acutephas
serum
drawn
soon
possibl
onset
ill
prefer
within
three
four
day
convalescentserum
two
four
week
later
antigen
detect
test
viral
isol
specimen
collect
soon
possibl
onset
ill
prefer
within
three
four
day
viral
isol
antigen
detect
nasopharyng
aspir
wash
prefer
nasopharyng
throat
swab
identifi
rsv
one
studi
show
nearli
increas
isol
rate
nasopharyng
wash
compar
nasopharyng
swab
isol
respiratori
virus
respiratori
secret
gener
provid
etiolog
diagnosi
although
care
need
interpret
signific
adenoviru
herpesviru
isol
sinc
shed
may
prolong
test
sensit
specif
depend
skill
person
perform
test
especi
fa
qualiti
reagent
thu
result
one
laboratori
may
quit
differ
anoth
clinician
awar
sensit
specif
test
perform
laboratori
use
diagnosi
viral
respiratori
infect
like
increasingli
reli
rapid
detect
test
clinic
specimen
antigen
detect
monoclon
antibodi
like
commonli
use
reagent
sinc
provid
sensit
specif
compar
anim
antiserum
without
variabl
qualiti
test
detect
viral
dna
virusspecif
compon
clinic
specimen
also
develop
may
improv
abil
detect
viral
respiratori
infect
nosocomi
viral
infect
increasingli
recogn
import
problem
studi
shown
caus
signific
morbid
prolong
hospit
death
especi
among
infant
children
respiratori
virus
probabl
import
viral
nosocomi
pathogen
often
occur
part
commun
outbreak
epidemiolog
outbreak
nosocomi
viral
respiratori
infect
begin
understood
guidelin
prevent
control
develop
influenza
recogn
nosocomi
pathogen
time
well
document
caus
outbreak
nurs
home
hospit
spread
explos
fashion
presum
aerosol
introduc
hospit
difficult
control
thu
although
effect
prevent
measur
well
studi
measur
vaccin
hospit
nurs
home
staff
restrict
visitor
influenza
likeil
like
effect
initi
influenza
commun
nosocomi
outbreak
occur
confirm
outbreak
occur
amantadin
prophylaxi
given
unvaccin
patient
staff
patient
influenza
isol
respiratori
syncyti
viru
shown
major
nosocomi
pathogen
pediatr
hospit
caus
signific
morbid
death
children
age
especi
compromis
cardiac
function
also
associ
outbreak
among
elderli
chroniccar
facil
caus
signific
morbid
death
spread
pathogen
requir
close
contact
may
occur
infect
hospit
staff
fomit
respiratori
syncyti
viru
spread
rapidli
influenza
thu
spread
hospit
like
prevent
separ
infect
uninfect
patient
cohort
staff
ill
patient
strict
hand
wash
use
gown
staff
may
prevent
spread
outbreak
parainfluenza
virus
implic
outbreak
pediatr
hospit
among
elderli
chroniccar
facil
spread
therefor
prevent
control
parainfluenza
virus
presum
similar
respiratori
syncyti
viru
adenovirus
implic
nosocomi
outbreak
among
children
adult
often
spread
patient
staff
usual
occur
sporad
part
recogn
commun
outbreak
prevent
control
outbreak
adenoviru
infect
infect
uninfect
patient
probabl
separ
staff
member
wear
gown
glove
strict
hand
wash
enforc
coronavirus
rhinovirus
known
import
nosocomi
pathogen
implic
nosocomi
outbreak
respiratori
ill
prevent
control
treatment
viral
respiratori
infect
prevent
control
treatment
viral
respiratori
infect
met
limit
success
vaccin
chemotherapeut
agent
gener
use
develop
influenza
anoth
approach
prevent
control
virus
interrupt
transmiss
viral
respiratori
ill
children
respiratori
virus
probabl
import
viral
nosocomi
pathogen
often
occur
part
commun
outbreak
epidemiolog
outbreak
nosocomi
viral
respiratori
infect
begin
understood
guidelin
prevent
control
develop
influenza
recogn
nosocomi
pathogen
time
well
document
caus
outbreak
nurs
home
hospit
spread
explos
fashion
presum
aerosol
introduc
hospit
difficult
control
thu
although
effect
prevent
measur
well
studi
measur
vaccin
hospit
nurs
home
staff
restrict
visitor
influenza
likeil
like
effect
initi
influenza
commun
nosocomi
outbreak
occur
confirm
outbreak
occur
amantadin
prophylaxi
given
unvaccin
patient
staff
patient
influenza
isol
lob
respiratori
syncyti
viru
shown
major
nosocomi
pathogen
pediatr
hospit
caus
signific
morbid
death
children
age
especi
compromis
cardiac
function
also
associ
outbreak
among
elderli
chroniccar
facil
caus
signific
morbid
death
spread
pathogen
requir
close
contact
may
occur
infect
hospit
staff
fomit
respiratori
syncyti
viru
spread
rapidli
influenza
thu
spread
hospit
like
prevent
separ
infect
uninfect
patient
cohort
staff
ill
patient
strict
hand
wash
use
gown
staff
may
prevent
spread
outbreak
parainfluenza
virus
implic
outbreak
pediatr
hospit
among
elderli
chroniccar
facil
spread
therefor
prevent
control
parainfluenza
virus
presum
similar
respiratori
syncyti
viru
adenovirus
implic
nosocomi
outbreak
among
children
adult
often
spread
patient
staff
usual
occur
sporad
part
recogn
commun
outbreak
prevent
control
outbreak
adenoviru
infect
infect
uninfect
patient
probabl
separ
staff
member
wear
gown
glove
strict
hand
wash
enforc
coronavirus
rhinovirus
known
import
nosocomi
pathogen
implic
nosocomi
outbreak
respiratori
ill
prevent
control
treatment
viral
respiratori
infect
prevent
control
treatment
viral
respiratori
infect
met
limit
success
vaccin
chemotherapeut
agent
gener
use
develop
influenza
anoth
approach
prevent
control
virus
interrupt
transmiss
studi
use
disinfect
appli
hand
environlnent
surfac
shown
either
equivoc
result
techniqu
practic
widespread
use
studi
nosocomi
respiratori
syncyti
viru
adenoviru
infect
suggest
interrupt
transmiss
possibl
separ
infect
uninfect
patient
use
gown
glove
strict
handwash
staff
member
addit
studi
method
interrupt
transmiss
respiratori
virus
especi
hospit
need
unit
state
vaccin
influenza
adenoviru
infect
licens
licens
influenza
vaccin
consist
inactiv
viru
use
vaccin
strongli
recommend
individu
greatest
risk
seriou
pulmonari
complic
death
follow
influenza
individu
includ
elderli
certain
chronic
underli
diseas
includ
acquir
congenit
heart
diseas
chronic
obstruct
pulmonari
diseas
renal
impair
diabet
mellitu
sever
anemia
condit
compromis
immun
system
unfortun
per
cent
million
peopl
highrisk
group
vaccin
year
unlik
vaccin
compon
strain
must
updat
frequent
keep
pace
antigen
chang
influenza
virus
influenza
vaccin
stimul
increas
antibodi
titer
per
cent
recipi
often
associ
compar
degre
protect
infect
live
attenu
oral
vaccin
adenovirus
use
militari
personnel
effect
reduc
acut
respiratori
diseas
recruit
experiment
vaccin
develop
number
respiratori
virus
consider
research
devot
develop
live
attenu
influenza
vaccin
administ
intranas
hope
simul
natur
infect
live
vaccin
effect
inactiv
one
vaccin
test
todat
howev
often
fail
induc
adequ
antibodi
respons
inseroposit
individu
associ
high
rate
advers
reaction
particularli
seroneg
individu
mani
serotyp
rhinovirus
thu
far
preclud
develop
vaccin
virus
sinc
natur
infect
respiratori
syncyti
viru
parainfluenza
viru
coronaviru
induc
shortterm
immun
reinfect
occur
throughout
life
prospect
vaccin
virus
less
promis
howev
infect
caus
respiratori
syncyti
viru
parainfluenza
viru
major
health
problem
infant
young
children
worldwid
consider
effort
made
develop
vaccin
age
group
inactiv
vaccin
respiratori
syncyti
viru
found
protect
may
predispos
recipi
sever
ill
subsequ
natur
infect
live
attenu
vaccin
respiratori
syncyti
viru
current
evalu
parenter
intranas
administr
thu
far
none
vaccin
shown
effect
vaccin
parainfluenza
virus
develop
l
j
anderson
p
patriarca
j
c
hierholz
g
r
nobl
studi
use
disinfect
appli
hand
environment
surfac
shown
either
equivoc
result
techniqu
practic
widespread
use
studi
nosocomi
respiratori
syncyti
viru
adenoviru
infect
suggest
interrupt
transmiss
possibl
separ
infect
uninfect
patient
use
gown
glove
strict
handwash
staff
member
addit
studi
method
interrupt
transmiss
respiratori
virus
especi
hospit
need
unit
state
vaccin
influenza
adenoviru
infect
licens
licens
influenza
vaccin
consist
inactiv
viru
use
vaccin
strongli
recommend
individu
greatest
risk
seriou
pulmonari
complic
death
follow
influenza
individu
includ
elderli
certain
chronic
underli
diseas
includ
acquir
congenit
heart
diseas
chronic
obstruct
pulmonari
diseas
renal
impair
diabet
mellitu
sever
anemia
condit
compromis
immun
system
unfortun
per
cent
million
peopl
highrisk
group
vaccin
year
unlik
vaccin
compon
strain
must
updat
frequent
keep
pace
antigen
chang
influenza
virus
influenza
vaccin
stimul
increas
antibodi
titer
per
cent
recipi
often
associ
compar
degre
protect
infect
live
attenu
oral
vaccin
adenovirus
use
militari
personnel
effect
reduc
acut
respiratori
diseas
recruit
experiment
vaccin
develop
number
respiratori
virus
consider
research
devot
develop
live
attenu
influenza
vaccin
administ
intranas
hope
simul
natur
infect
live
vaccin
effect
inactiv
one
vaccin
test
date
howev
often
fail
induc
adequ
antibodi
respons
seroposit
individu
associ
high
rate
advers
reaction
particularli
seroneg
individu
mani
serotyp
rhinovirus
thu
far
preclud
develop
vaccin
virus
sinc
natur
infect
respiratori
syncyti
viru
parainfluenza
viru
coronaviru
induc
shortterm
immun
reinfect
occur
throughout
life
prospect
vaccin
virus
less
promis
howev
infect
caus
respiratori
syncyti
viru
parainfluenza
viru
major
health
problem
infant
young
children
worldwid
consider
effort
made
develop
vaccin
age
group
inactiv
vaccin
respiratori
syncyti
viru
found
protect
may
predispos
recipi
sever
ill
subsequ
natur
infect
live
attenu
vaccin
respiratori
syncyti
viru
current
evalu
parenter
intranas
administr
thu
far
none
vaccin
shown
effect
vaccin
parainfluenza
virus
develop
use
recolubin
technolog
clone
peptid
synthesi
may
futur
contribut
improv
vaccin
respiratori
virus
chemotherapi
antivir
chemotherapi
avail
treatment
prophylaxi
influenza
infect
amantadin
hydrochlorid
symmetrel
shown
effect
treatment
prophylaxi
influenza
infect
probabl
interf
penetr
step
viral
replic
mg
per
day
amantadin
begun
within
first
hour
ill
durat
uncompl
ill
viru
shed
shorten
extent
smallairway
abnorm
reduc
unknown
whether
amantadin
effect
treat
primari
influenza
pneumonia
taken
daili
durat
epidem
influenza
gener
week
amantadin
shown
per
cent
effect
prevent
infect
consid
substitut
vaccinationi
amantadin
primarili
excret
unmetabol
urin
thu
may
accumul
renal
function
impair
side
effect
common
includ
difficulti
concentr
confus
hallucin
anxieti
insomnia
anorexia
dyspepsia
occur
per
cent
adult
studi
sever
investig
antivir
drug
yield
promis
result
rimantadin
analog
amantadin
appear
effect
treatment
prophylaxi
influenza
amantadin
ribavirin
synthet
ribonucleosid
exhibit
vitro
vivo
activ
number
virus
includ
influenza
b
respiratori
syncyti
viru
ill
clinic
studi
infect
caus
influenza
b
respiratori
syncyti
viru
achiev
promis
result
administ
aerosol
lace
mask
interferon
administ
nasal
spray
challeng
rhinoviru
appear
delay
onset
decreas
sever
symptom
infect
volunt
investig
drug
includ
isoprinosin
prophylaxi
treatment
infect
due
influenza
enviroxim
vitamin
c
common
cold
far
shown
effect
viral
respiratori
ill
like
continu
fact
life
time
symptomat
therapi
intervent
avail
clinician
instanc
howev
patient
seriou
ill
patient
compromis
immun
cardiac
respiratori
system
hospit
patient
develop
like
permit
effect
intervent
serious
ill
use
trade
name
identif
impli
endors
public
health
servic
unit
state
depart
health
human
servic
use
recombin
technolog
clone
peptid
synthesi
may
futur
contribut
improv
vaccin
respiratori
antivir
chemotherapi
avail
treatment
prophylaxi
influenza
infect
amantadin
hydrochlorid
symmetrel
shown
effect
treatment
prophylaxi
influenza
infect
probabl
interf
penetr
step
viral
replic
mg
per
day
amantadin
begun
within
first
hour
ill
durat
uncompl
ill
viru
shed
shorten
extent
smallairway
abnorm
reduc
unknown
whether
amantadin
effect
treat
primari
influenza
pneumonia
taken
daili
durat
epidem
influenza
gener
week
amantadin
shown
per
cent
effect
prevent
infect
consid
substitut
vaccin
amantadin
primarili
excret
unmetabol
urin
thu
may
accumul
renal
function
impair
side
effect
common
includ
difficulti
concentr
confus
hallucin
anxieti
insomnia
anorexia
dyspepsia
occur
per
cent
adult
studi
sever
investig
antivir
drug
yield
promis
result
rimantadin
analog
amantadin
appear
effecti
treatment
prophylaxi
influenza
amantadin
ribavirin
synthet
ribonucleosid
exhibit
vitro
vivo
activ
number
virus
includ
influenza
b
respiratori
syncyti
viru
ill
clinic
studi
infect
caus
influenza
b
respiratori
syncyti
viru
achiev
promis
result
administ
aerosol
lace
mask
interferon
administ
nasal
spray
challeng
rhinoviru
appear
delay
onset
decreas
sever
symptom
infect
volunteerslsl
investig
drug
includ
isoprinosin
prophylaxi
treatment
infect
due
influenza
enviroxim
vitamin
c
common
far
shown
effect
viral
respiratori
ill
like
continu
fact
life
time
symptomat
therapi
intervent
avail
clinician
instanc
howev
patient
seriou
ill
patient
compromis
immun
cardiac
respiratori
system
hospit
patient
develop
like
permit
effect
intervent
seriouslv
ill
use
trade
name
identif
impli
endors
public
health
servic
unit
state
depart
health
human
servic
immunocompromis
patient
diagnosi
viral
respiratori
infect
may
permit
clinician
discontinu
antibiot
initi
appropri
antivir
therapi
hospit
patient
diagnosi
viral
respiratori
infect
may
alert
medic
staff
possibl
nosocomi
outbreak
prompt
initi
appropri
control
measur
diagnosi
control
treatment
viral
respiratori
infect
becom
scientif
curiositythey
import
part
clinician
armamentarium
immunocompromis
patient
diagnosi
viral
respiratori
infect
may
permit
clinician
discontinu
antibiot
initi
appropri
antivir
therapi
hospit
patient
diagnosi
viral
respiratori
infect
may
alert
medic
staff
possibl
nosocomi
outbreak
prompt
initi
appropri
control
measur
diagnosi
control
treatment
viral
respiratori
infect
becom
scientif
curiositythey
import
part
clinician
armamentarium
